rs767788896
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_StrongBP6_ModerateBP7
The NM_000022.4(ADA):c.6C>T(p.Ala2Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000306 in 1,537,918 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000020 ( 1 hom., cov: 32)
Exomes 𝑓: 0.000032 ( 1 hom. )
Consequence
ADA
NM_000022.4 synonymous
NM_000022.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.731
Publications
544 publications found
Genes affected
ADA (HGNC:186): (adenosine deaminase) This gene encodes an enzyme that catalyzes the hydrolysis of adenosine to inosine in the purine catabolic pathway. Various mutations have been described for this gene and have been linked to human diseases related to impaired immune function such as severe combined immunodeficiency disease (SCID) which is the result of a deficiency in the ADA enzyme. In ADA-deficient individuals there is a marked depletion of T, B, and NK lymphocytes, and consequently, a lack of both humoral and cellular immunity. Conversely, elevated levels of this enzyme are associated with congenital hemolytic anemia. [provided by RefSeq, Sep 2019]
ADA Gene-Disease associations (from GenCC):
- severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Myriad Women’s Health, Orphanet
- Omenn syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -7 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 20-44651602-G-A is Benign according to our data. Variant chr20-44651602-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 536192.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.731 with no splicing effect.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ADA | NM_000022.4 | c.6C>T | p.Ala2Ala | synonymous_variant | Exon 1 of 12 | ENST00000372874.9 | NP_000013.2 | |
| ADA | NM_001322051.2 | c.6C>T | p.Ala2Ala | synonymous_variant | Exon 1 of 11 | NP_001308980.1 | ||
| ADA | NR_136160.2 | n.98C>T | non_coding_transcript_exon_variant | Exon 1 of 11 | ||||
| ADA | NM_001322050.2 | c.-284C>T | 5_prime_UTR_variant | Exon 1 of 11 | NP_001308979.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ADA | ENST00000372874.9 | c.6C>T | p.Ala2Ala | synonymous_variant | Exon 1 of 12 | 1 | NM_000022.4 | ENSP00000361965.4 | ||
| ADA | ENST00000695995.1 | c.6C>T | p.Ala2Ala | synonymous_variant | Exon 1 of 9 | ENSP00000512318.1 | ||||
| ADA | ENST00000695991.1 | c.6C>T | p.Ala2Ala | synonymous_variant | Exon 1 of 8 | ENSP00000512314.1 | ||||
| ADA | ENST00000696038.1 | n.6C>T | non_coding_transcript_exon_variant | Exon 1 of 9 | ENSP00000512344.1 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151582Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
3
AN:
151582
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000102 AC: 14AN: 137560 AF XY: 0.000131 show subpopulations
GnomAD2 exomes
AF:
AC:
14
AN:
137560
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000317 AC: 44AN: 1386336Hom.: 1 Cov.: 31 AF XY: 0.0000438 AC XY: 30AN XY: 685546 show subpopulations
GnomAD4 exome
AF:
AC:
44
AN:
1386336
Hom.:
Cov.:
31
AF XY:
AC XY:
30
AN XY:
685546
show subpopulations
African (AFR)
AF:
AC:
0
AN:
30850
American (AMR)
AF:
AC:
0
AN:
36942
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25012
East Asian (EAS)
AF:
AC:
0
AN:
35750
South Asian (SAS)
AF:
AC:
34
AN:
79670
European-Finnish (FIN)
AF:
AC:
0
AN:
34238
Middle Eastern (MID)
AF:
AC:
0
AN:
4320
European-Non Finnish (NFE)
AF:
AC:
9
AN:
1081854
Other (OTH)
AF:
AC:
1
AN:
57700
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151582Hom.: 1 Cov.: 32 AF XY: 0.0000405 AC XY: 3AN XY: 74016 show subpopulations
GnomAD4 genome
AF:
AC:
3
AN:
151582
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
74016
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41258
American (AMR)
AF:
AC:
0
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5136
South Asian (SAS)
AF:
AC:
2
AN:
4780
European-Finnish (FIN)
AF:
AC:
0
AN:
10540
Middle Eastern (MID)
AF:
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
AC:
1
AN:
67860
Other (OTH)
AF:
AC:
0
AN:
2082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency Benign:1
Nov 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.